Max Brodermann is a UCL PhD student and Haematology Registrar (ST6) specializing in cancer research, focusing on fusion protein–driven malignancies. Previously, Max worked as a doctor at various NHS trusts and completed a research project at the Wellcome Trust Centre for Human Genetics, exploring the effects of exercise on vein grafts. Max holds a Bachelor of Medicine, Bachelor of Surgery from the University of Oxford and a Postgraduate Certificate in Medical Education with distinction from Staffordshire University. As a trustee for Cancer52, Max advocates for improved support and treatment for rare and less common cancers.
This person is not in the org chart
This person is not in any teams
This person is not in any offices